Nordson Corporation · NASDAQ:NDSN

Nordson — Q2 2023 Earnings Presentation

16 slides from Nordson's earnings presentation, May 23, 2023

  1. Slide 1: 2Q Fiscal 2023 Webcast

    2Q Fiscal 2023 Webcast May 23, 2023 NBS NEXT OWNER MINDSET WINNING TEAMS

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement Click to edit title Under the Private Securities Litigation Reform Act of 1995 Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by

  3. Slide 3: Agenda

    Agenda 2Q Fiscal 2023 Webcast – May 23, 2023  Second Quarter Highlights  Sales Performance and Earnings Review  Balance Sheet and Cash Flow  Enterprise Performance  FY 2023 and 3Q 2023 Guidance  Q&A Sundaram Nagarajan Joseph Kelley Lara Mahoney President and Executive Vice President, Vice Pres

  4. Slide 4: Q2 2023 Highlights

    Q2 2023 Highlights • Organic sales growth of 1% compared to prior year  Diversification of business allows us to navigate thru a multi-speed economy • Targeted cost actions to support profitable growth • Remain invested in competitive differentiators – customer-centric business model, precision tec

  5. Slide 5: Total Company – 2Q 2023

    Total Company – 2Q 2023 Sales  Reported sales increased 2%  1% organic growth; 3% acquisitive growth; (2)% currency translation  Organic sales increase was driven by strong 7% growth in Asia Pacific, partially reflecting the timing difference related to Chinese New Year Operating Profit* 2Q 2022

  6. Slide 6: Industrial Precision Solutions – 2Q 2023

    Industrial Precision Solutions – 2Q 2023 Sales  Sales of $336 million, a 6% sales increase  Organic sales growth of 9% was offset by unfavorable foreign currency of 2%  Organic growth was driven by robust demand in the polymer processing product lines, as well as products sold into consumer non-d

  7. Slide 7: Medical and Fluid Solutions – 2Q 2023

    Medical and Fluid Solutions – 2Q 2023 Sales  Sales of $167 million, decreased 3%  Strong demand for medical interventional solutions product lines was offset by significant softness in medical fluid components for biopharma applications and fluid solutions product lines. Operating Profit and Margi

  8. Slide 8: Advanced Technology Solutions – 2Q 2023

    Advanced Technology Solutions – 2Q 2023 Sales  Sales of $148 million, increase of 1%  12% increase from acquisition, partially offset by 10% decrease in organic sales and an unfavorable currency impact of 2%.  Organic sales decrease driven by electronics dispense product lines serving semi market

  9. Slide 9: Balance Sheet and Cash Flow

    Balance Sheet and Cash Flow Strong Cash Flow with Sufficient Liquidity to Invest in Strategic Initiatives Net Debt Free Cash Flow  2023 Net Debt increase driven by CyberOptics  Strong free cash flow of $159 million acquisition  Year-to-date cash conversion rate on net income  1.0 net debt levera

  10. Slide 10: End Market Visibility

    End Market Visibility Industrial Precision Solutions Medical and Fluid Solutions Advanced Technology Solutions • Steady demand in industrials and • Strong growth in medical interventional • Continued weakness in semi-conductor consumer non-durable product lines solutions (i.e., balloons, catheters,

  11. Slide 11: Full-Year Fiscal 2023 Guidance

    Full-Year Fiscal 2023 Guidance Full-Year Sales Guidance Updating guidance, sustaining $2,362 $2,590 $2,590 - $2,667 record 2022 sales performance  Sustaining fiscal 2023 sales growth guidance of 0% - 3%  Narrowing adjusted earnings range to $8.90 to $9.30 2021 2022 2023  Remain invested in innova

  12. Slide 12: 3Q Fiscal 2023 Guidance

    3Q Fiscal 2023 Guidance 3Q 2023 Sales Guidance Steady Growth $662 $655 - $670 $647  Order entry was steady throughout the quarter, reflects a less than 1.0 book-to-bill ratio  Backlog remains strong in historical terms at $950 million, heavily weighted toward systems and medical interventional sol

  13. Slide 13: Questions?

    Questions? Giordson

  14. Slide 14: Non-GAAP Definitions

    Appendix Non-GAAP Definitions This presentation contains references to non-GAAP financial information. Although these are non-GAAP measures, we believe that they are useful to an investor in evaluating the company performance for the period presented. These non-GAAP definitions include:  Adjusted o

  15. Slide 15: Reconciliation of Non-GAAP Measures

    Reconciliation of Non-GAAP Measures Adjusted Operating Profit and EBITDA (Dollars in thousands) 15

  16. Slide 16: Reconciliation of Non-GAAP Measures

    Reconciliation of Non-GAAP Measures Profitability (Dollars in thousands) 16

Nordson — Q2 2023 Earnings Presentation on 6ix